DENTSPLY SIRONA Inc. (LON:0I8F)
London
· Delayed Price · Currency is GBP · Price in USD 16.76
+0.02 (0.09%)
At close: Jul 3, 2025
DENTSPLY SIRONA Revenue
DENTSPLY SIRONA had revenue of $879.00M USD in the quarter ending March 31, 2025, a decrease of -7.76%. This brings the company's revenue in the last twelve months to $3.72B, down -5.61% year-over-year. In the year 2024, DENTSPLY SIRONA had annual revenue of $3.79B, down -4.34%.
Revenue (ttm)
$3.72B
Revenue Growth
-5.61%
P/S Ratio
0.84
Revenue / Employee
$265.64K
Employees
14,000
Market Cap
2.43B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.79B | -172.00M | -4.34% |
| Dec 31, 2023 | 3.97B | 43.00M | 1.10% |
| Dec 31, 2022 | 3.92B | -309.00M | -7.30% |
| Dec 31, 2021 | 4.23B | 892.00M | 26.71% |
| Dec 31, 2020 | 3.34B | -683.00M | -16.98% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| GSK plc | 31.53B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |
DENTSPLY SIRONA News
- 21 days ago - Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields - Benzinga
- 22 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dentsply Sirona Inc. (XRAY) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 24 days ago - Dentsply Sirona Inc. (XRAY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire
- 27 days ago - Dentsply Sirona Inc. (XRAY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Accesswire
- 4 weeks ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Dentsply Sirona Inc. (XRAY) And Encourages Investors to Connect - Accesswire
- 4 weeks ago - INVESTOR NOTICE: Kaskela Law LLC Announces Investigation of Dentsply Sirona Inc. and Encourages Long-Term Dentsply Investors to Contact the Firm - XRAY - Accesswire
- 4 weeks ago - Bronstein, Gewirtz & Grossman, LLC Encourages Dentsply Sirona Inc. (XRAY) Stockholders to Inquire about Securities Investigation - Accesswire
- 4 weeks ago - Dentsply Sirona prices offering of $550M of junior subordinated notes - Seeking Alpha